Violation Tracker Parent Company Summary

Parent Company Name: 
Currax Pharmaceuticals
Ownership Structure: 
privately held
Headquartered in: 
New Jersey
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Penalty total since 2000: 
$3,610,001
Number of records: 
3
Top 5 Offense Groups (Groups Defined)Penalty TotalNumber of Records
healthcare-related offenses$2,800,0001
government-contracting-related offenses$800,0001
employment-related offenses$10,0011
Top 5 Primary Offense TypesPenalty TotalNumber of Records
off-label or unapproved promotion of medical products$2,800,0001
False Claims Act and related$800,0001
benefit plan administrator violation$10,0011
Notes: 

Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Associated Names: 

CYPRESS PHARMACEUTICAL; PERNIX THERAPEUTICS, LLC


Individual Penalty Records:

Click on the company or penalty amount for more information on each case.
Download results as CSV or XML
Company Primary Offense Type Year Agency Penalty Amountsort icon
Cypress Pharmaceutical Inc. off-label or unapproved promotion of medical products 2012 FDA $2,800,000
Pernix Therapeutics False Claims Act and related 2013 LA-AG $800,000
PERNIX THERAPEUTICS, LLC benefit plan administrator violation 2019 EBSA $10,001
Download results as CSV or XML